Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
7749.T
Strong BuyMedikit Co.,Ltd. · Healthcare · Japan · $258M · Avg Vol: $36K/d
98
StockRankGet insider-trade alerts
Q
70
V
76
M
65
P/E (TTM)
13.8x
ROE
6.9%
D/E
0.0x
Dividend %
3.5%
COMPANY DESCRIPTION
Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, and sells medical devices related to blood vessels and blood in Japan and internationally.
FINANCIAL SUMMARY (JPY)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 21.6B | 21.9B | 22.6B | 23.8B | 3.2% | 24.4B |
| EPS (JPY) | 170.67 | 187.95 | 204.55 | 206.37 | 6.5% | 207.73 |
| Shares | 16.8M | 14.8M | 14.6M | 14.5M | -13.8% | 14.5M |
| Debt | — | — | 0 | 19.0M | — | 17.1M |
| Equity | 47.3B | 44.1B | 45.2B | 46.8B | -0.4% | — |
| Op CF | 4.5B | 4.8B | 3.6B | 4.7B | 1.9% | 4.8B |
| Inv CF | -3.6B | 3.2B | -3.9B | -1.3B | — | — |
| Fin CF | -1.5B | -6.6B | -1.9B | -1.8B | — | — |
Loading 1Y...
PRICE (1Y)+2.1%
SMA 50SMA 200
Close
$17.92
RSI (14)
60.7
52W High
$19.02
From 52W High
0.9%
SCORE BREAKDOWN
Quality
70
ROIC
9.4%71.9
ROE
6.9%62.4
GP/Assets
17.4%41.2
Op. Margin
19.9%81.9
FCF/Assets
2.4%56.9
Piotroski
497.6
Int. Cover
50.0x89.3
D/E Ratio
0.00x94.8
Current Ratio
6.52x77.8
Value
76
P/E (TTM)
13.8x77.0
EV/EBITDA
3.3x97.1
P/FCF
32.8x40.8
P/B
0.9x87.8
P/S
1.7x72.4
Div Yield
3.5%76.1
Momentum
65
52W High %
94%90.7
RS 6M
-19%44.2
SMA 50/200
0.98x54.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
33%66.6
FUNDAMENTALS
Market Cap
$258M
P/E (Forward)
—
Gross Margin
38.1%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 7749.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 7749.T | Medikit Co.,Ltd.(you) | $258M | 98 | Strong Buy |
| 5889.T | Japan Eyewear Holdings Co., Ltd. | $403M | 98 | Strong Buy |
| 368A.T | Kitazato Corporation | $375M | 96 | Strong Buy |
| 7743.T | SEED Co.,Ltd. | $139M | 95 | Strong Buy |
| 7979.T | Shofu Inc. | $519M | 94 | Strong Buy |
| 262A.T | Intermestic Inc. | $348M | 80 | Buy |
| 197A.T | TAUNS Laboratories,Inc. | $339M | 75 | Buy |
| 3154.T | Medius Holdings Co., Ltd. | $111M | 82 | Strong Buy |
| 7775.T | Daiken Medical Co., Ltd. | $77M | 87 | Strong Buy |
| 3046.T | JINS HOLDINGS Inc. | $878M | 85 | Strong Buy |
Peer medians: ROE 8.4% · P/E 16.6x · Gross margin 46.9%